CD274 and lymphoma: Izquierdo et al. revealed that loss of TP53 function in lymphoma led to increased EV production and that TP53-deficient lymphoma B-cell EVs inhibited Fc receptor-dependent macrophage ADCP and induced chemoimmunotherapy resistance through PD-L1 expression.